Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

cycloSPORINE ophthalmic

cycloSPORINE ophthalmic
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Restasis EMULSION, OPHTHALMIC 0.05%      
Verkazia EMULSION, OPHTHALMIC 0.1%      
Cequa SOLUTION, OPHTHALMIC 0.9 mg/mL      
VIEW MORE Anti-inflammatory Agents, Miscellaneous
Comments:

Inpatients may use home supply of Restasis, Cequa, or Verkazia.

 

If requested, an order for artificial tears 1 drop in each eye q2 hrs PRN dry eyes may be entered per protocol.

 

Reviewed: November 2021 (Cequa) , December 2024 (Verkazia)

Updated: November 2021 (Restasis)

 

Cyclosporine ophthalmic emulsion (VERKAZIA) Spotlight.pdf

Last updated: Feb. 3, 2025
Rhazdrugs cycloSPORINE ophthalmic






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved